Veranstaltungsprogramm
Eine Übersicht aller Sessions/Sitzungen dieser Tagung.
Bitte wählen Sie einen Ort oder ein Datum aus, um nur die betreffenden Sitzungen anzuzeigen oder eine einzelne Sitzung um die gegebenenfalls vorhandenen Abstracts einsehen zu können.
|
Sitzungsübersicht |
Datum: Donnerstag, 06.02.2025 | |
10:30 - 12:00 |
Career Workshop: The importance of a network for your scientific career Ort: Saal B Chair: Claudia Göttsch, TU Dresden, Deutschland Chair: Holger Winkels, Universität zu Köln, Deutschland |
12:00 - 12:30 |
Presidents Opening Ort: Saal B Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Chair: Oliver Weingärtner, Universitätsklinikum Jena, Deutschland |
12:30 - 13:15 |
Keynote - Panagiotis Deloukas Ort: Saal B Chair: Winfried März, Synlab Holding Deutschland GmbH, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Genetic Risk Scores Oueen Mary University of London, London, Vereinigtes Königreich |
13:15 - 13:30 |
Break / Exhibition / Industry Symposium 13:15 - 14:20 Ort: Foyer |
13:30 - 14:20 |
Kardiovaskuläre Prävention – Zeit zu handeln! - presented by Amgen Ort: Saal B Chair: Tienush Rassaf, Universitätsklinikum Essen, Deutschland Kardiovaskuläre Prävention – wo stehen wir in Deutschland? Universitätsklinikum Essen, Essen, Deutschland Erfolgreiche Integration des Lipidmanagements – Wie wichtig sind funktionierende Versorgungsstrukturen? Praxis für Prävention und kardiovaskuläre Medizin, Essen, Deutschland Lp(a) – ein unterschätzter Risikofaktor für kardiovaskuläre Erkrankungen? Universitätsklinikum Köln (AöR), Köln, Deutschland |
14:20 - 16:00 |
Inherited metabolic disorders Ort: Saal B Chair: Stefan R. Bornstein, Universitätsklinikum Carl Gustav Carus, Deutschland Chair: Ulrike Schatz, Universitätsklinikum Dresden, Deutschland The polygenic nature of hypertriglyceridemia Medical Faculty Mannheim at the University of Heidelberg, Mannheim Genetics of LDL-C- and Lp(a) metabolism Deutsches Herzzentrum München, München, Deutschland Genetics (and Epigenetics) of Diabetes Mellitus Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, Nuthetal, Deutschland Genetics of adiposity Universitätsklinikum Essen, Essen, Deutschland |
16:00 - 16:15 |
Break and Exhibition 16:00 - 17:00 Ort: Foyer |
16:15 - 17:00 |
Neueste Fortschritte in der medikamentösen Behandlung von Adipositas bei kardiologischen Patienten – presented by Novo Nordisk Ort: Saal B Chair: Shibu Mathew, Universitätsmedizin Essen, Deutschland GLP-1 RA – Eine feste Säule in der kardiovaskulären Prävention? Universitätsklinikum Freiburg, Freiburg, Deutschland |
17:00 - 18:40 |
Young Investigator Award Session Ort: Saal B Chair: Karsten Grote, Philipps-Universität Marburg, Deutschland Chair: Daniel Sedding, Universitätsklinikum Halle, Deutschland Longitudinal Assessment of Sub-clinical Arterial Inflammation in Patients Receiving Immune-Checkpoint Inhibitors by Sequential [18F]FDG PET Scans Uniklinik Freiburg, Freiburg, Germany Hyperinsulinemia promotes atherosclerosis by inducing metabolic reprogramming of autoreactive CD4+ T cells 1: La Jolla Institute for Immunology, La Jolla, CA, USA; 2: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 3: Immunology Center of Georgia (IMMCG), Augusta University, Augusta, GA, USA; 4: Carter Immunology Center, University of Virginia, Charlottesville, VA, United States; 5: Cardiovascular Research Center, University of Virginia, Charlottesville, VA, United States; 6: Division of Cardiovascular Medicine/Department of Medicine, University of Virginia, Charlottesville, VA, United States Adenosine deaminase acting on RNA-2 (ADAR2) controls atherosclerosis progression in mice and humans 1: Department of Cardiovascular Research, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.; 2: Biosciences Institute, Vascular Biology and Medicine Theme, Faculty of Medical Sciences, Newcastle University, Newcastle Upon Tyne, UK.; 3: Department of Clinical Therapeutics, National and Kapodistrian University of Athens Medical School, Athens, Greece. Bidirectional crosstalk between macrophages and the heart: drivers of function and dysfunction post-injury. 1: Universitätsklinikum Freiburg, Freiburg, Germany; 2: Institute for Experimental Cardiovascular Medicine, University Heart Center Freiburg-Bad Krozingen, Germany; 3: Institute for Disease Modelling and Targeted Medicine (IMITATE), University Clinic Freiburg, Germany; 4: Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany Intestinal leukocytes regulate cardiac remodeling after myocardial infarction 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kinder- und Jugendmedizin, Uniklinik RWTH Aachen, Aachen, Deutschland; 5: Department III of Internal Medicine, Heart Center, University Hospital of Cologne Accumulation of gut-derived metabolite phenylacetylglutamine in chronic kidney disease promotes cardiac remodeling and is associated with cardiovascular and overall mortality 1: Uniklinik RWTH Aachen, Department of Cardiology, Angiology and Critical Care (Medical Clinic 1), Aachen, Germany; 2: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 3: Department of Nephrology and Kidney Transplantation, University Hospitals Leuven, Leuven, Belgium; 4: Uniklinik RWTH Aachen, Interdisciplinary Center for Clinical Research (IZKF) Genomics Facility, Aachen, Germany Characterization of IFNIC macrophages as potential therapeutic target in experimental aneurysm using scRNA- and CITE-sequencing 1: Division for Cardiology, Pulmonology and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Genomics and Transcriptomics Laboratory, Biologisch-Medizinisches-Forschungszentrum (BMFZ), Heinrich-Heine University Düsseldorf, Germany; 3: Department of Cardiology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany; 4: Institute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany |
18:40 - 21:00 |
Poster Session with "Wine & Cheese" Ort: Foyer Chair: Yvonne Döring, Universitätsspital Bern, Schweiz Chair: Michael Torzewski, Robert-Bosch-Krankenhaus GmbH, Deutschland Chair: Dennis Wolf, Uniklinik Freiburg, Deutschland Chair: Andreas Zirlik, Medizinische Universität Graz, Österreich C-reactive protein and cardiovascular risk in 454,203 individuals without ASCVD 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Gastroenterologie, Stoffwechselerkrankungen und Internistische Intensivmedizin (Medizinische Klinik III), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Gefäßchirurgie, Uniklinik RWTH Aachen, Aachen, Deutschland Characterizing the leukocyte diversity of the arterial vasculature in healthy mice by nuclear and single-cell RNA sequencing University Hospital Freiburg, Freiburg im Breisgau, Deutschland CKD triggers enhanced cardiac dysfunction, inflammation and metabolic alterations after myocardial infarction 1: Institute for Molecular Cardiovascular Research (IMCAR), Uniklinik RWTH Aachen, RWTH Aachen University, Aachen, Germany; 2: Department of Internal Medicine I, Cardiology, Uniklinik RWTH Aachen, Aachen, Germany; 3: Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Germany; 4: Institute of Pathology, Uniklinik RWTH Aachen, Aachen, Germany Comparative Effects of Nano/Microparticles on NF-κB Activation: Implications for Inflammation Beyond Microplastics Cardiology and Angiology, Philipps-University Marburg, Germany Effect of Myocardial Infarction on the immune response in the melanoma tumor immune microenvironment 1: Department III of Internal Medicine, Heart Center, University Hospital, University of Cologne, Cologne, Germany; 2: Center for Molecular Medicine Cologne, Cologne, Germany; 3: Institute of Experimental Oncology, University of Bonn, Bonn, Germany Exposure to dietary α-amylase-trypsin inhibitors (ATI) induces vascular inflammation and endothelial dysfunction 1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany Hypercholesterolemia triggers innate immune imbalance and transforms brain infarcts after stroke 1: Institute of Experimental Immunology and Imaging, University of Duisburg-Essen, Essen, Germany; 2: Leibniz-Institut für Analytische Wissenschaften - ISAS -e.V., Dortmund, Germany; 3: Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany Inhibition of B cell activation by Ibrutinib improves cardiac function in experimental myocardial infarction in mice University Heart Centre Freiburg-Bad Krozingen, Medical Centre, University of Freiburg, Germany Kynurenine predicts outcome in pulmonary infections with a link to cardiac dysfunction 1: Uniklinik RWTH Aachen, Medizinische Klinik 1, Aachen, Deutschland; 2: Uniklinik RWTH Aachen, Medizinische Klinik 5, Aachen, Deutschland; 3: Uniklinik RWTH Aachen, Medizinische Klinik 3, Aachen, Deutschland; 4: Nephrology and Renal Transplantation Research Group, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium; 5: Uniklinik RWTH Aachen, Institut für Pathologie, RWTH centralized Biomaterial Bank, Aachen, Deutschland Ligature-induced Periodontitis Alters Hematopoiesis and Aggravates Atherosclerotic Plaque Formation in Mice 1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: Polyclinic for Operative Dentistry and Periodontology, Faculty of Medicine and University Hospital Cologne; 5: Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Gießen Liver fat content predicts cardiovascular events in 39,953 individuals without ASCVD 1: Department of Internal Medicine I – Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital RWTH Aachen, Germany; 2: Department of Medicine III – Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Germany; 3: Medical Department 1, Technische Universität Dresden, Germany; 4: The Institute for Translational Medicine and Therapeutics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA Mex3a protects against atherosclerosis: evidence from mice and humans. 1: Institute for Cardiovascular Prevention, Ludwig-Maximilians-Universität, Munich, Germany; 2: German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Germany; 3: Institute for Genetic and Biomedical Research, Unit of Milan, National Research Council, Italy Neutrophils Extracellular Traps Myeloperoxidase and Elastase Predict Cerebral Vasospasms after Aneurysmal Subarachnoid Hemorrhage 1: Department of Oral, Maxillofacial and Facial Plastic Surgery, University Hospital Düsseldorf, Düsseldorf, Germany; 2: Medical Faculty and University Hospital Düsseldorf, Düsseldorf, Deutschland; 3: Department of Neurology, University Hospital Düsseldorf, Düsseldorf, Germany Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis 1: The first affiliated Hospital of Sun Yat Sen University; 2: Institute for cardiovascular prevention, LMU, Munich Product problems of in vitro diagnostics for differential diagnostics of myocardial infarction and pulmonary embolism – Analysis of field safety notes published by BfArM between 2014 and 2023 1: Pharmazeutisches Institut Universität Bonn, Bonn, Deutschland; 2: Institut für Ernährungswissenschaften, Friedrich-Schiller-Universität Jena; 3: Synlab Akademie, Mannheim Role of complement in adhering platelets and immune cells to endothelium of various organs 1: UMM, Mannheim, Deutschland; 2: Eberhard Karls Universität Tübingen Senolytic Therapy Reduces IL-6-Mediated Inflammation in the Diabetic Heart 1: 1Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Molecular Radiooncology Clinic for Radiation Therapy and Radiooncology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany Senolytics restore diabetes-induced aortic dysfunction in DIO mice 1: Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Deutschland; 2: Institute for Translational Pharmacology, Medical Faculty and University Hospital, Heinrich-Heine University, Düsseldorf, Germany; 3: Cardiovascular Research Institute Düsseldorf (CARID), Medical Faculty, Heinrich Heine University, Düsseldorf, Germany; 4: Division of Cardiac Surgery, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine-University Düsseldorf, Germany Sex-related differences of cardiovascular health in a murine model of celiac disease 1: Laboratory for Molecular Cardiology, University Hospital Mainz, Germany; 2: Institute of Translational Immunology, University Hospital Mainz, Germany; 3: Department of Medicine, Cardiology, Goethe University Hospital, Frankfurt, Germany T regulatory cells (Tregs) lose their protective phenotype in patients with coronary artery disease (CAD) Universitätsklinikum Freiburg, Freiburg, Germany The Effects of Fasting on Leukocyte Trafficking in Organ Crosstalk 1: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin (Medizinische Klinik I), Uniklinik RWTH Aachen, Aachen, Deutschland; 2: Klinik für Nieren- und Hochdruckkrankheiten, Rheumatologische und Immunologische Erkrankungen (Medizinische Klinik II), Uniklinik RWTH Aachen, Aachen, Deutschland; 3: Klinik für Pneumologie und Internistische Intensivmedizin (Medizinische Klinik V), Uniklinik RWTH Aachen, Aachen, Deutschland; 4: Klinik für Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum Halle (Saale), Halle (Saale), Deustchland The human early atherosclerotic lesion: Insights from Technovit® embedding and integrative imaging 1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, 70376 Stuttgart, Germany; 2: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany The Role of Enzymatically Modified LDL (eLDL) and Angiopoietin-like Protein 4 (ANGPTL4) in Aortic Valve Stenosis 1: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP), Stuttgart, Deutschland; 2: Department of Cardiovascular Surgery, Robert-Bosch-Hospital, 70376 Stuttgart, Germany; 3: Department of Laboratory Medicine and Hospital Hygiene, Robert-Bosch-Hospital, 70376 Stuttgart, Germany The role of Fumarate hydratase 1 (Fh1) in foam cell formation 1: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany; 2: Center of Cardiovascular Medicine (CCM ABCD) – Aachen, Bonn, Cologne, Düsseldorf; 3: Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; 4: University of Cologne, Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany; 5: University of Cologne, Faculty of Mathematics and Natural Sciences, Institute of Genetics, Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), Cologne, Germany Unraveling T regulatory cell instability and protective immunity loss in murine atherosclerosis Vascular Immunology lab, Department of Cardiology and Angiology, University Heart Centre Freiburg-Bad Krozingen, Freiburg, Germany. Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk Factors UKE, Hamburg, Hamburg, Deutschland Assessing the role of olfactory receptor 2 in a diet-induced obesity animal model University Hospital Cologne, Cologne, Deutschland |
Impressum · Kontaktadresse: Datenschutzerklärung · Veranstaltung: VMAC 2025 |
Conference Software: ConfTool Pro 2.6.153 © 2001–2025 by Dr. H. Weinreich, Hamburg, Germany |